CureVac BV (CVAC) Stock Price Today
Key Stats
- $1.05BMarket Cap
- -Volume
- HealthSector
- $5.6052W High
- $2.5952W Low
- -Typical Hold Time
- $599.28MEnterprise Value
- -Div Yield
- -Trading Activity
Track CureVac BV (CVAC) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, CureVac BV has traded between a low of $2.59 and a high of $5.6, highlighting its annual price range. Buy and sell CureVac BV shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About CureVac BV
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its initial public offering in August 2020. CureVac is collaborating with GlaxoSmithKline to develop a second-generation COVID-19 vaccine. CureVac's first attempt to develop a COVID-19 vaccine did not have sufficient efficacy data, and its trials were discontinued in October 2021. The company's other pipeline candidates include mRNA vaccines for influenza, rabies, and malaria. Additionally, CureVac is in the early stages of development for oncology and molecular therapies spanning tumors, liver, ocular, and lung diseases.
Most Recent News
Figma's General Counsel sells 211,599 shares worth $6.3 million.
The General Counsel of Figma has sold 211,599 shares, generating $6.3 million in proceeds. This significant insider sale could indicate personal financial planning or a shift in confidence, which investors might watch closely. The impact on Figma's s...
S&P 500 drops 0.71%, nearing oversold territory on 10-day advance/decline line
The S&P 500 index fell by 0.71% on Tuesday, with its 10-day advance/decline line approaching oversold levels for the first time since early May. This indicates weakening market breadth as the index has seen limited gains and multiple short losing str...
Shipping stocks hit decade highs amid Strait of Hormuz crisis, driven by soaring freight rates and supply disruptions.
Shares of shipping companies have surged to their highest levels in over a decade due to a prolonged crisis in the Strait of Hormuz, which has disrupted global vessel supply. Freight rates and stock prices have soared as tankers are forced onto longe...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.